For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Drs. Buck, Levin, Meinke, and their colleagues, including two Pharmacology PhD students, Tom Rossetti and Jacob Ferreira, have a new publication just out in ACS Medicinal Chemistry Letters titled: Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10). Very nice work! Click here for more.